3 completed, 1 recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Recruiting 1 |
Follow Lower Respiratory Tract Infection: new trials by email Literature Review of Lower Respiratory Tract Infection trials Research Report on Lower Respiratory Tract Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China Nirsevimab, Placebo - Lower Respiratory Tract Infection | Phase 3 | Completed | AstraZeneca | 800 | 2021-11-24 | 2026-10-15 |
| Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study DAS181, Placebo, DAS181 COVID-19 - Lower Respiratory Tract Infection, Parainfluenza | Phase 3 | Recruiting | Ansun Biopharma, Inc. | 274 | 2019-05-23 | 2026-06-23 |
| A Trial to Reduce Pneumonia in Nursing Home Residents Enhanced Oral Care, Usual oral care - Pneumonia, Lower Respiratory Tract Infection | Phase 3 | Completed | Yale University | 834 | 2009-10-01 | 2014-11-20 |
| Oseltamivir Randomised Controlled Efficacy Trial Oseltamivir, Placebo - Influenza, Pneumonia | Phase 3 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 1190 | 2008-05-01 | 2018-06-06 |
Pneumonia (2) · Bronchiolitis (1) · COVID-19 (1) · Coronavirus Infections (1) · Influenza, Human (1) · Otitis Media (1) · Paramyxoviridae Infections (1) · Respiratory Tract Infections (1)
Infections (3) · Lung Diseases (3) · Respiratory Tract Diseases (3) · RNA Virus Infections (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Bronchial Diseases (1) · Bronchitis (1) · Coronaviridae Infections (1) · Ear Diseases (1) · Lung Diseases, Obstructive (1) · Mononegavirales Infections (1) · Nidovirales Infections (1) · Orthomyxoviridae Infections (1) · Otitis (1)
Oseltamivir (1) · nirsevimab (1) · oplunofusp (1)
Ansun Biopharma, Inc. (1) · AstraZeneca (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · Yale University (1)
China (2) · United States (2) · Australia (1) · Bangladesh (1) · South Korea (1) · Taiwan (1)
Dorothy Baker, PhD (1) · Manisha Juthani-Mehta, MD (1) · Mary Tinetti, MD (1) · Peter Peduzzi, PhD (1) · Ronald B Moss, MD (1) · Vincent J Quagliarello, MD (1) · W. Abdullah Brooks, MD, MPH (1)
PMID 24268590, PMID 25520333, PMID 25788164
2018 (1), R01AG030575 (1), U01IP000127 (1)